R

PriceRadiopharm Theranostics

RADX

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Historical stock price chart and annual return over the past years

-73%

4 months

% Total

RADX